A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies (original) (raw)
Impact of dermatologic adverse events induced by targeted therapies on quality of life
Michèle Verschoore
Critical Reviews in Oncology/Hematology, 2016
View PDFchevron_right
Dermatologic Events in Oncology: How to Measure the Impact of Dermatologic and Mucosal Adverse Events on Symptom Burden and Quality of Life
Christine B Boers-Doets
View PDFchevron_right
Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel
Veronica Moura
Anais Brasileiros de Dermatologia, 2020
View PDFchevron_right
Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
C. Beato
Clinical and Translational Oncology
View PDFchevron_right
Dermatological side effects of immunotherapy drugs and targeted cancer therapies: Importance of dermatology and oncology collaboration
Uğur Çelik
Journal of Oncology Pharmacy Practice, 2020
View PDFchevron_right
Interventions for skin reactions associated with targeted anticancer treatments
T. Stijnen, Christine B Boers-Doets
Reviews, 1996
View PDFchevron_right
Skin adverse events in recently approved targeted therapies in solid malignancies
Racha Dib
Future Oncology, 2018
View PDFchevron_right
Non-Rash Dermatologic Adverse Events Related to Targeted Therapies
Christine B Boers-Doets
Seminars in Oncology Nursing, 2014
View PDFchevron_right
Dermatologic Reactions to Targeted Therapy
Dr margaret Barton Burke
Nursing Clinics of North America, 2017
View PDFchevron_right
Outcome assessment in dermatology clinical trials and cochrane reviews: call for a dermatology‐specific outcome taxonomy
Jan Kottner
Journal of the European Academy of Dermatology and Venereology, 2020
View PDFchevron_right
Dermatological Side Effects of Cancer Treatment: Psychosocial Implications-A Systematic Review of the Literature
Maria Alzira P Dinis, Maria Ferreira, André Louro, Vera Almeida
Healthcare, 2023
View PDFchevron_right
Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts
Matteo Auriemma
OncoTargets and Therapy
View PDFchevron_right
Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma
Richard Carvajal
Journal of cancer research and clinical oncology, 2016
View PDFchevron_right
Algorithm for dermocosmetic use in the management of cutaneous side‐effects associated with targeted therapy in oncology
B. Dreno
Journal of the European Academy of Dermatology and Venereology, 2013
View PDFchevron_right
Impact of Measuring Patient-Reported Outcomes in Dermatology Drug Development
Susan Zelt
The Patient - Patient-Centered Outcomes Research, 2016
View PDFchevron_right
Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
Claire Habito
Journal of the American Academy of Dermatology, 2014
View PDFchevron_right
Impact of Chemotherapy and Radiation on Skin Health in Cancer Patients (Atena Editora)
Atena Editora
Impact of Chemotherapy and Radiation on Skin Health in Cancer Patients (Atena Editora), 2024
View PDFchevron_right
Targeted therapy in oncology patients and skin: Pharmaceutical and dermocosmetic management
fotini mellou
Journal of Cosmetic Dermatology, 2019
View PDFchevron_right
The Prospective Observational Study on Cutaneous Adverse Drug Reactions to Chemotherapy
Prakash Mani
Journal of Evidence Based Medicine and Healthcare, 2016
View PDFchevron_right
A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013
Siu-fun Wong
Journal of Patient-Reported Outcomes
View PDFchevron_right
Inter-observer agreement between dermatologists and oncologists in assessing dermatological toxicities in patients with metastatic colorectal cancer treated by cetuximab-based chemotherapies: A pilot comparative study
Bernard Guillot, Fabienne Portales
European Journal of Cancer, 2010
View PDFchevron_right
Economic Burden of Dermatologic Adverse Events Induced by Molecularly Targeted Cancer Agents
Cara Calahan, Mary Kwasny
Archives of Dermatology, 2011
View PDFchevron_right
Effects of epidermal growth factor receptor inhibitor-induced dermatologic toxicities on quality of life
SARA GIL ORTIZ
Cancer, 2010
View PDFchevron_right
Patient-Reported Outcome Measures in Dermatology: A Systematic Review
Jennifer Austin
Acta Dermato Venereologica, 2021
View PDFchevron_right
Dermatological Adverse Effects of Chemotherapeutic Agents: Experience from a Tertiary Centre
Vikas Roshan
Journal of Evolution of Medical and Dental Sciences, 2017
View PDFchevron_right
The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy: a randomized controlled pilot trial
Lærke Tolstrup
Journal of Patient-Reported Outcomes
View PDFchevron_right
Cutaneous side effects of molecularly targeted therapies for the treatment of solid tumors
Karine Turke
Drugs in context, 2018
View PDFchevron_right
Systematic review with meta-analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib
Ferran Torres
Alimentary Pharmacology & Therapeutics
View PDFchevron_right
Skin Malignancies Due to Anti-Cancer Therapies
Luca Rapparini
Cancers, 2024
View PDFchevron_right
Skin care management in cancer patients: an evaluation of quality of life and tolerability
Cara Calahan
Supportive Care in Cancer, 2011
View PDFchevron_right
The Role of Therapy in Impairing Quality of Life in Dermatological Patients: A Multinational Study
Ilknur K I V A N Ç Altunay
Acta dermato-venereologica, 2018
View PDFchevron_right
Quality of life in colon cancer patients with skin side effects: preliminary results from a monocentric cross sectional study
Federica Andreis
Health and Quality of Life Outcomes, 2010
View PDFchevron_right
Dermatologic adverse effects of breast cancer chemotherapy: a longitudinal prospective observational study with a review of literature
narges alizadeh
International Journal of Dermatology, 2020
View PDFchevron_right
Management of EGFR Inhibitor-induced Skin Toxicity and Factors Impacting Patients’ Adherence to Skin Toxicity Treatment: Health Care Provider and Patient Surveys in European Oncology Centers
Sabada Dube
Clinical Colorectal Cancer, 2020
View PDFchevron_right
OTT 127795 skin toxicity evaluation in patient treated with cetuximab f 061617 (3)
Giu Di M
View PDFchevron_right